<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00403559</url>
  </required_header>
  <id_info>
    <org_study_id>CASM981CUS37</org_study_id>
    <secondary_id>SAIRB # 06-4893</secondary_id>
    <secondary_id>IND 75,225</secondary_id>
    <nct_id>NCT00403559</nct_id>
  </id_info>
  <brief_title>A 4 Week Study of Elidel for the Treatment of Seborrheic Dermatitis</brief_title>
  <official_title>A 4 Week Randomized Double-Blind Parallel Group Active Comparator Controlled Study of Elidel for the Treatment of Seborrheic Dermatitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dermatology Specialists Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Novartis</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Dermatology Specialists Research</source>
  <brief_summary>
    <textblock>
      This is an exploratory study to determine effectiveness of Elidel for the treatment of
      seborrheic dermatitis
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a 4 week study for patients 18 and olderto compare the efficacy and safety of
      pimecrolimus cream 1% twice daily and ketaconazole cream 2 % twice daily for the treatment of
      seborrheic dermatitis.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2007</start_date>
  <completion_date type="Actual">January 2009</completion_date>
  <primary_completion_date type="Actual">January 2009</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The change of IGA from BL to wk 1 will be the primary efficacy variable</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Key secondary efficacy will be the % of patients with facial clearance</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Seborrheic Dermatitis</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Elidel</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Must be 18 or older and sign written informed consent.

          -  Must be wiling and able to comply with protocol.

          -  Must have active seborrheic dermatitis of the face.

        Exclusion Criteria:

          -  No history of overt bacterial, viral or fungal infection of the head/neck.

          -  No history or presence of compromising dermatosis elsewhere on the skin

          -  No Parkinson's disease, HIV, infections or disorders of the central nervous system

          -  No actinically damaged skin
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven Kempers, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Associated Skin Care Specialists</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bernard Goffe, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dermatology Associates</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Debra Breneman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Cincinnati - Dermatology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dermatology Specialists</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 21, 2006</study_first_submitted>
  <study_first_submitted_qc>November 22, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 23, 2006</study_first_posted>
  <last_update_submitted>March 31, 2009</last_update_submitted>
  <last_update_submitted_qc>March 31, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 1, 2009</last_update_posted>
  <responsible_party>
    <name_title>Joseph F Fowler JR., M.D&gt;</name_title>
    <organization>Dermatology Specialists</organization>
  </responsible_party>
  <keyword>seborrheic dermatitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dermatitis</mesh_term>
    <mesh_term>Dermatitis, Seborrheic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pimecrolimus</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>November 22, 2013</submitted>
    <submission_canceled>Unknown</submission_canceled>
    <submitted>December 9, 2013</submitted>
    <returned>February 6, 2014</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

